These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8391399)

  • 21. Reducing cardiac filling pressure lowers norepinephrine spillover in patients with chronic heart failure.
    Azevedo ER; Newton GE; Floras JS; Parker JD
    Circulation; 2000 May; 101(17):2053-9. PubMed ID: 10790346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of norepinephrine and isoproterenol clearance in congestive heart failure.
    Leuenberger U; Kenney G; Davis D; Clemson B; Zelis R
    Am J Physiol; 1992 Jul; 263(1 Pt 2):H56-60. PubMed ID: 1636772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac and systemic sympathetic activity in response to clonidine in human heart failure.
    Azevedo ER; Newton GE; Parker JD
    J Am Coll Cardiol; 1999 Jan; 33(1):186-91. PubMed ID: 9935028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac sympathetic denervation in Parkinson disease.
    Goldstein DS; Holmes C; Li ST; Bruce S; Metman LV; Cannon RO
    Ann Intern Med; 2000 Sep; 133(5):338-47. PubMed ID: 10979878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiadrenergic effect of chronic amiodarone therapy in human heart failure.
    Kaye DM; Dart AM; Jennings GL; Esler MD
    J Am Coll Cardiol; 1999 May; 33(6):1553-9. PubMed ID: 10334423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects.
    Brunner-La Rocca HP; Kaye DM; Woods RL; Hastings J; Esler MD
    J Am Coll Cardiol; 2001 Apr; 37(5):1221-7. PubMed ID: 11300426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.
    Goldstein DS; Holmes C; Frank SM; Dendi R; Cannon RO; Sharabi Y; Esler MD; Eisenhofer G
    Circulation; 2002 Oct; 106(18):2358-65. PubMed ID: 12403667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity.
    Mansfield D; Kaye DM; Brunner La Rocca H; Solin P; Esler MD; Naughton MT
    Circulation; 2003 Mar; 107(10):1396-400. PubMed ID: 12642360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure.
    Kingwell BA; Thompson JM; Kaye DM; McPherson GA; Jennings GL; Esler MD
    Circulation; 1994 Jul; 90(1):234-40. PubMed ID: 8026003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure.
    Newton GE; Parker JD
    Circulation; 1996 Aug; 94(3):353-8. PubMed ID: 8759076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.
    Goldstein DS; Eisenhofer G; Stull R; Folio CJ; Keiser HR; Kopin IJ
    J Clin Invest; 1988 Jan; 81(1):213-20. PubMed ID: 3335637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo measurement of neuronal uptake of norepinephrine in the human heart.
    Goldstein DS; Brush JE; Eisenhofer G; Stull R; Esler M
    Circulation; 1988 Jul; 78(1):41-8. PubMed ID: 3383409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disposition of endogenous adrenaline compared to noradrenaline released by cardiac sympathetic nerves in the anaesthetized dog.
    Eisenhofer G; Smolich JJ; Esler MD
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):160-71. PubMed ID: 1570020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digoxin reduces cardiac sympathetic activity in severe congestive heart failure.
    Newton GE; Tong JH; Schofield AM; Baines AD; Floras JS; Parker JD
    J Am Coll Cardiol; 1996 Jul; 28(1):155-61. PubMed ID: 8752808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans.
    Esler MD; Wallin G; Dorward PK; Eisenhofer G; Westerman R; Meredith I; Lambert G; Cox HS; Jennings G
    Am J Physiol; 1991 Apr; 260(4 Pt 2):R817-23. PubMed ID: 2012253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parasympathetic control of cardiac sympathetic activity: normal ventricular function versus congestive heart failure.
    Azevedo ER; Parker JD
    Circulation; 1999 Jul; 100(3):274-9. PubMed ID: 10411852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure.
    Himura Y; Felten SY; Kashiki M; Lewandowski TJ; Delehanty JM; Liang CS
    Circulation; 1993 Sep; 88(3):1299-309. PubMed ID: 8102598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy.
    Brush JE; Eisenhofer G; Garty M; Stull R; Maron BJ; Cannon RO; Panza JA; Epstein SE; Goldstein DS
    Circulation; 1989 Apr; 79(4):836-44. PubMed ID: 2924414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac sympathetic responses to acute vasodilation. Normal ventricular function versus congestive heart failure.
    Newton GE; Parker JD
    Circulation; 1996 Dec; 94(12):3161-7. PubMed ID: 8989124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dialysate dihydroxyphenylglycol as a window for in situ axoplasmic norepinephrine disposition.
    Yamazaki T; Akiyama T; Kitagwa H; Kawada T; Sunagawa K
    Neurochem Int; 2001 Mar; 38(3):287-92. PubMed ID: 11099788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.